ベータ・ミオシンの重鎖遺伝子変異によって引き起こされる高濃縮性心筋疾患におけるテンポラルリポラライゼーション可動性
W L Atiga1, L Fananapazir, D McAreavey
1Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
Circulation
|March 22, 2000
まとめ
ベータ-ミオシン重鎖 (ベータ-MHC) 遺伝子変異によって引き起こされる高縮性心筋症候群 (HCM) の患者は,異常な心臓再極化を示します. QT変動性分析で特定されたこの不安定な再偏極化は,突然の心臓死のリスクを増やす可能性があります.
科学分野:
- 心臓病学 心臓病学
- 遺伝学 遺伝学とは
- 電気生理学 電気生理学
背景:
- 遺伝子の変異に関連した多動性心筋症 (HCM) は突然死のリスクを増大します.
- QT変動性分析は,心房不律症の高リスク患者を特定するためのツールです.
- ベータ-ミオシン重鎖 (β-MHC) 遺伝子変異は,HCMの既知の原因である.
研究 の 目的:
- ベータ-MHC遺伝子変異を有するHCM患者で,不安定な心室リポラライゼーションを示すかどうかを調査する.
- これらの患者におけるビート・トゥ・ビートQT変動分析の有用性を評価する.
- 特定のベータ-MHC変異とQT変動異常を相関させるため.
主な方法:
- QT変動指数と心拍数-QT間隔の相関性は,ホルターモニターを使用して測定されました.
- ベータ-MHC変異によるHCMを患った36人の患者が研究されました.
- 年齢と性別が一致する26人の健康な個人が対照群として使用されました.
主要な成果:
- HCM患者では,対照群と比較して,QT変動指数が著しく高かった.
- Arg{403}Glnβ-MHC変異を有する患者は,QT変動異常が最も顕著であった.
- 低心率-QT区間の相関性は,HCM患者,特にArg{403}-Gln変異を有する患者で観察されました.
結論:
- ベータ-MHC遺伝子変異を有するHCM患者は,不安定な再極化を示しており,突然死のリスクが高いことを示唆しています.
- QTの変動性分析は,HCMにおけるリポラライゼーション異常を定量化することができます.
- Arg(403) Glnのような特定のβ-MHC変異は,より深刻なQT変動と関連しており,予後が悪いことを示しています.
さらに関連する動画
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
関連する概念動画
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:30Cardiac Action Potential
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...